NCT06184880 Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer
| NCT ID | NCT06184880 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier de Valence |
| Condition | Upper Aerodigestive Tract Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2024-03-19 |
| Primary Completion | 2029-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2024-03-19 with a primary completion date of 2029-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
APAORL2 study aims to evaluate the efficacy of a physical activity program on the sedentary and physical activity level during the 18-month program. APAORL2 study is a randomized, open label, controlled, monocentric, intervention study that will be conducted among 96 patients treated for localized upper aerodigestive tract cancer.
Eligibility Criteria
Inclusion Criteria: * Patients ≥18 years * newly diagnosed, histologically proven Upper Aerodigestive Tract Cancer, non-metastatic, * life expectancy ≥18 months * having a smartphone, tablet or computer with an internet connection enabling remote physical Activity sessions for the experimental group Exclusion Criteria: * Presenting a contraindication to moderate physical activity * Deprived of their liberty by court or administrative decision * Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,
Contact & Investigator
Guillaume Guillaume
PRINCIPAL INVESTIGATOR
CH VALENCE
Frequently Asked Questions
Who can join the NCT06184880 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Upper Aerodigestive Tract Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06184880 currently recruiting?
Yes, NCT06184880 is actively recruiting participants. Contact the research team at gbuiret@ch-valence.fr for enrollment information.
Where is the NCT06184880 trial being conducted?
This trial is being conducted at Valence, France.
Who is sponsoring the NCT06184880 clinical trial?
NCT06184880 is sponsored by Centre Hospitalier de Valence. The principal investigator is Guillaume Guillaume at CH VALENCE. The trial plans to enroll 96 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.